Results 41 to 50 of about 222,467 (377)
The Omnipod DASH™ Insulin Management System (Insulet Corp, Billerica, MA) is a discreet, tubeless, wearable insulin pump that holds up to 200 units of U-100 insulin and delivers therapy through customizable basal rates and bolus amounts.
Trang T. Ly +4 more
semanticscholar +1 more source
MJA Practice Essentials - 2: Recent advances in therapy of diabetes - Endocrinology [PDF]
The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.As suboptimal blood glucose control has a lasting harmful effect even if control improves ...
Chan JL +6 more
core +1 more source
OBJECTIVE To investigate temporal trends and contemporary use of insulin pump therapy and glucose monitoring in type 1 diabetes. RESEARCH DESIGN AND METHODS In a population-based study, we analyzed the use of insulin pump therapy, continuous glucose ...
Louisa van den Boom +13 more
semanticscholar +1 more source
An increasing number of patients with type 2 diabetes mellitus (T2DM) use insulin pumps. The first insulin pumps especially designed for patients with T2DM have recently become available. However, national guidelines do not primarily recommend the use of
G. Freckmann +7 more
semanticscholar +1 more source
Real-World Analysis of Therapeutic Outcome in Type 1 Diabetes Mellitus at a Tertiary Care Center [PDF]
Insulin replacement in type 1 diabetes mellitus (T1DM) needs intensified treatment, which can either be performed by multiple daily injections (MDI) or continuous subcutaneous insulin infusion (CSII).
Antonia Kietaibl +2 more
doaj +1 more source
IN BRIEF Insulin pump therapy is advancing rapidly. This article summarizes the variety of insulin pump technologies available to date and discusses important clinical considerations for each type of technology.
Cari Berget +2 more
semanticscholar +1 more source
Type 1 diabetes is a chronic autoimmune disease characterised by insulin deficiency and resultant hyperglycaemia. Knowledge of type 1 diabetes has rapidly increased over the past 25 years, resulting in a broad understanding about many aspects of the ...
DiMeglio, Linda A. +2 more
core +1 more source
Aim. To evaluate the importance of insulin pump therapy for the achievement of DM1 compensation in children of different age. Materials and methods. The study included 36 patients aged 5-18 years with DM1.
Nina Viktorovna Bolotova +3 more
doaj +1 more source
Continuous subcutaneous insulin infusion (CSII) is commonly used in patients with diabetes. Accurate and reliable delivery by insulin pumps is essential for a safe and effective therapy, particularly when using small doses.
R. Ziegler +5 more
semanticscholar +1 more source
This article is the answer to the letter sent by Gorbachev to the editor. It deals with problems and difficulties encountered by diabetic patients using insulin pumpsand systems for continuous glucose monitoring in real time are considered.
Yury Ivanovich Filippov +2 more
doaj +1 more source

